Skip to main content

Table 3 Detection (n d ) and quantification (n q ) incidences and concentration ranges of blood volatile organic compounds

From: Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease

Class

VOC

CAS

Blood before HD

Blood after HD

Wilcoxon blood before/after

Contaminants

Incidence

Range (median)

Incidence

Range (median)

Tubing

Membrane

nd(nq)

[nmol/L]

nd(nq)

[nmol/L]

VSC

Dimethyl sulfide (DMS)

75-18-3

14(14)

2.3-146(18.7)

14(14)

1.2-38.7(5.7)

<0.001

  

Thiophene

110-02-1

8(6)

0.11-0.66(0.13)

2(1)

0.36

0.03

  

Sulfide, allyl methyl (AMS)

10152-76-8

8(8)

0.6-13(3.3)

8(6)

0.67-3.7(2.4)

0.02

  

Sulfide, methyl propyl (MPS)

3877-15-4

11(8)

0.7-56(4.3)

10(7)

0.4-17.5(1.1)

0.008

  

Ketones

Acetone

67-64-1

14(14)

n.q.

14(14)

n.q.

-

3-Buten-2-one

78-94-4

7(7)

488-7370(1090)

10(10)

385-47360(1170)

n.s.

 

2,3-Butanedione

431-03-8

1(1)

967

1(1)

285

-

  

2-Butanone

78-93-3

14(14)

13-1895(60)

14(14)

32-4330(164)

n.s.

  

2-Pentanone

107-87-9

14(14)

11.5-387(68)

14(14)

31.3-341(77)

n.s.

  

2-Hexanone

591-78-6

4(2)

2.4-3.2(2.8)

7(5)

0.4-6.8(0.75)

n.s.

 

Cyclohexanone

108-94-1

8(8)

57-478(238)

8(8)

11-780(150)

n.s.

 

2-Cyclohexen-1-one

930-68-7

4(4)

73-344(232)

4(4)

55-225(98.5)

-

 

4-Heptanone

123-19-3

14(14)

1.8-130(35)

14(14)

14.5-200(41)

0.03

  

3-Heptanone

106-35-4

8(8)

1.5-148(5)

9(9)

1.5-87(2.6)

n.s.

 

2-Heptanone

110-43-0

9(9)

1.5-31(6)

12(12)

3.5-128(19)

<0.001

  

Ald.

2-Propenal

107-02-8

8(8)

4080-26100(12800)

3(3)

10200-15200(14800)

n.s.

 

Propanal*

123-38-6

7(7)

5.9-44(17.5)

5(5)

6.5-820(23)

n.s.

 

2-Propenal, 2-methyl-

78-85-3

1(1)

54

1(1)

54

-

 

Hydrocarbons

Propane, 2-methyl-

75-28-5

1(1)

1.1

0(0)

<LOD

-

1,3-Butadiene

106-99-0

2(2)

0.57-0.9(0.74)

1(1)

0.27

-

  

n-Butane

106-97-8

7(7)

0.5-2.3(1.25)

5(5)

0.4-5.6(1.2)

n.s.

Butane, 2-methyl-

78-78-4

7(7)

0.21-2.2(0.57)

2(2)

0.12-0.46(0.29)

n.s.

 

Isoprene

78-79-5

14(14)

1.3-25.6(4.1)

14(14)

2.8-36(6.6)

<0.001

  

2-Pentene, (Z)-

627-20-3

2(2)

0.13-0.6(0.37)

2(2)

0.1-0.27(0.19)

-

 

n-Pentane

109-66-0

6(6)

0.35-2(0.67)

7(7)

0.3-2.7(1.1)

n.s.

1,3-Pentadiene, (E)-

2004-70-8

2(2)

0.6-0.9(0.74)

1(1)

0.28

-

  

1,3-Pentadiene, (Z)-

1574-41-0

2(2)

0.17-0.18(0.17)

1(1)

0.07

-

  

1-Pentene, 2-methyl-

763-29-1

0(0)

<LOD

0(0)

<LOD

-

 

Pentane, 2-methyl-

107-83-5

5(4)

1.1-4.8(2.4)

5(3)

1.1-2.5(2.1)

n.s.

Cyclohexane

110-82-7

1(1)

0.27

0(0)

<LOD

-

1-Hexene

592-41-6

4(4)

0.15-8.7(3.3)

5(5)

0.09-6.1(0.4)

-

 

Pentane, 3-methyl-

96-14-0

2(0)

<LOQ

2(0)

<LOQ

-

 

n-Hexane

110-54-3

10(10)

0.09-7.3(0.35)

9(9)

0.16-2.9(0.33)

n.s.

Hexane, 2-methyl-

591-76-4

4(4)

0.22-0.83(0.28)

4(4)

0.20-0.4(0.24)

-

 

1-Heptene

592-76-7

2(2)

0.28-0.63(0.46)

1(1)

1.8

-

  

2-Heptene

592-77-8

1(1)

3.8

1(1)

2.7

-

 

n-Heptane

142-82-5

8(8)

0.36-2(0.6)

7(7)

0.4-2.3(0.6)

n.s.

Heptane, 3-methylene-

1632-16-2

9(9)

0.09-52(0.62)

10(10)

0.26-44(0.95)

n.s.

 

3-Octene, (E)-

14919-01-8

5(5)

0.2-16(0.75)

5(5)

0.3-12(1.6)

-

 

Heptane, 2,4-dimethyl-

2213-23-2

0(0)

<LOD

0(0)

<LOD

-

 

Terpenes

α-Pinene

80-56-8

6(6)

13.7-239(48)

6(6)

13.4-183(35.5)

0.03

 

3-Carene

13466-78-9

12(12)

6.2-116(12.5)

12(11)

4-65(11.6)

n.s.

 

m-Cymene

535-77-3

1(1)

2.33

1(1)

2

-

  

p-Cymene

99-87-6

14(14)

3.4-84.5(17)

14(14)

3.6-69.5(11.7)

n.s.

  

DL-Limonene

138-86-3

13(13)

22.6-982(163)

13(13)

23.7-1210(109)

n.s.

  

Eucalyptol

470-82-6

2(2)

126-310(218)

2(2)

79-173(126)

-

  

Aromatics

Benzene

71-43-2

10(10)

0.14-7.1(1)

5(5)

0.19-2.33(1.3)

0.01

  

Toluene

108-88-3

11(11)

0.28-14(1.2)

10(10)

0.22-9.5(0.65)

0.01

 

p-Xylene

106-42-3

13(13)

0.36-9.4(0.9)

11(11)

0.44-6.2(1.2)

n.s.

 

o-Xylene

95-47-6

2(2)

0.39-2.7(1.54)

2(2)

0.17-0.24(0.21)

-

  

Heterocyclic

Furan

110-00-9

7(7)

0.06-37(0.7)

9(9)

0.21-113(1.7)

0.03

 

Furan, 2-methyl-

534-22-5

5(5)

0.18-6.3(0.7)

5(5)

0.1-1.7(0.6)

-

  

Furan, 3-methyl-

930-27-8

4(4)

0.07-0.37(0.08)

4(4)

0.06-0.16(0.07)

-

  

Pyrrole

109-97-7

2(2)

16-20.8(18.4)

0(0)

<LOD

-

  

Pyrimidine

289-95-2

9(8)

15.9-485(45)

8(8)

22.4-166(44.5)

n.s.

  

Furan, 2,5-dimethyl-

625-86-5

3(3)

0.25-2.6(2.16)

3(3)

0.25-2.45(1.29)

-

  

Pyridine

110-86-1

10(10)

11.4-359(28.6)

8(8)

7.2-47(22.6)

n.s.

  

Furan, 2-pentyl-

3777-69-3

5(4)

11-68(13)

5(3)

10-34(13)

n.s.

  

Other

Acetonitrile

75-05-8

6(6)

201-6790(835)

4(4)

180-2280(1000)

-

  

Ethyl Acetate

141-78-6

2(2)

0.9-916(458)

2(2)

25.4-53(39)

-

  
  1. n.s. – not significant. Isoprene increases in concentration during dialysis, whereas dimethyl sulfide (DMS), methyl propyl sulfide (MPS) and benzene decrease in concentration during dialysis. *Due to some technical problems breath profiles of one patient were excluded from the data analysis.